glp-1 news today november 2025 ISPOR 2025: Exploring reasons for discontinuation GLP-1 Receptor Agonist Market Valued
Description
To put this into context, Ozempic was first approved (for diabetes) in 2017
It was now, officially, a cardiovascular risk-reduction drug
[DOI] [PMC free article] [PubMed] [Google Scholar] 175.Nunn E, et al
220/shot vial format 1,2901,750/month at typical titration
Paleo and keto both cut processed foods, but they work very differently
